L08847 2,2-Di-n-propylacetamide, 97%
SDS
| Stock No. | Size | Price ($) | Quantity | Availability |
|---|---|---|---|---|
| L08847-06 | 5g | 83.10 |
|
|
| L08847-14 | 25g | 276.00 |
|
|
2,2-Di-n-propylacetamide, 97%
Chemical Properties
Applications
It is employed as an antiepileptic drug. It is hydrolyzed quickly to VPA in vivo, but has intrinsic anticonvulsant activity. Also a reactant used in the synthesis of mutual prodrugs containing bio-cleavable and drug releasable disulfide linkers.
Notes
Literature References
Ilan Winkler; Simcha Blotnik; Jakob Shimshoni; Boris Yagen; Marshall Devor; Meir Bialer. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain. British Journal of Pharmacology. 2005, 146 (2), 198-208.
Galit Shaltiel et. al. Valproate decreases inositol biosynthesis. Biological Psychiatry. 2004, 56(11), 868-874.
GHS Hazard and Precautionary Statements
Hazard Statements: H302
Harmful if swallowed.
Precautionary Statements: P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. Dispose of contents/container in accordance with local/regional/national/international regulations.
